IHS FormWeb
Approved Formulary
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
IHS FormWeb
Approved Formulary
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Webpage Links
Search results for:
amantadine
amantadine
Brand names:
Symmetrel
Form
Strength
CAPSULE, ORAL
100 mg
SYRUP, ORAL
50 mg/5 mL
Display
Adamantanes
,
Antiparkinsonian Agents
,
Adamantanes
Class:
081804
,
120804
,
283604
Medication comments:
Per policy, these drugs are subject to renal dosing adjustments by pharmacy.
Renal Dosing Program
View all
Generic + Route
(Brand)
• Indications
Usual Adult Dose
Comments
Renal Dosage Adjustments
amantadine
PO
(
Symmetrel
©
)
• Non-Parkinson's
100 mg q12h
CrCl > 50: No adjustment necessary
CrCl 30-50: 200 mg x1, then 100 mg q24h
CrCl 15-29: 200 mg x1, then 100 mg q48h
CrCl <15: 200 mg q7days
HD/PD: 200 mg q7days
Last updated:
May. 1, 2024
Renal Adjustment Policy
amantadine subject to adjustments by pharmacy.
Look-Alike/Sound-Alike
amantadine confused with amiodarone
UpToDate
FDA DailyMed Package Insert
MedLinePlus (Patient Information)
MSDS Online
(Brand)
• Indications
Comments
(Symmetrel©)
• Non-Parkinson's
CrCl 30-50: 200 mg x1, then 100 mg q24h
CrCl 15-29: 200 mg x1, then 100 mg q48h
CrCl <15: 200 mg q7days
HD/PD: 200 mg q7days